Nektar Therapeutics (NKTR) Misses Q4 EPS by 178c

March 12, 2026 4:36 PM EDT
Get Alerts NKTR Hot Sheet
Price: $72.26 -2.38%

Financial Fact:
Net loss: -43.22M

Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE

Nektar Therapeutics (NASDAQ: NKTR) reported Q4 EPS of ($1.78). Revenue for the quarter came in at $21.81 million.

For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK